Neovacs: HY 2015 Results (Neovacs) - Oct 4, 2015 - Anticipated filing of IND for P2a trial in SLE in US in early 2016; Anticipated initiation of P1/2a trial (N=30) in adult dermatomyositis in 2016; Anticipated data from P2b IFN-K-002 trial in SLE in Q1 2017
Anticipated IND • Anticipated new P1/2 trial • Anticipated P2b data • Immunology • Lupus
|